CN101011395A - 盐酸尼卡地平缓释制剂及其制备方法 - Google Patents
盐酸尼卡地平缓释制剂及其制备方法 Download PDFInfo
- Publication number
- CN101011395A CN101011395A CN 200710019925 CN200710019925A CN101011395A CN 101011395 A CN101011395 A CN 101011395A CN 200710019925 CN200710019925 CN 200710019925 CN 200710019925 A CN200710019925 A CN 200710019925A CN 101011395 A CN101011395 A CN 101011395A
- Authority
- CN
- China
- Prior art keywords
- hydrochloride
- preparation
- release
- licardipine hydrochloride
- licardipine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicinal Preparation (AREA)
Abstract
Description
主药及辅料名称 | 重量(克) |
盐酸尼卡地平 | 20 |
微晶纤维素 | 20 |
乳糖 | 130 |
羧甲基淀粉钠 | 18 |
聚乙烯吡咯烷酮K-30 | 12 |
纯化水 | 80 |
主药及辅料名称 | 重量(克) |
盐酸尼卡地平 | 20 |
微晶纤维素 | 33 |
甘露醇 | 130 |
低取代羟丙基纤维素 | 15 |
聚乙烯吡咯烷酮K-30 | 12 |
纯化水 | 80 |
主药及辅料名称 | 重量(克) |
盐酸尼卡地平 | 40 |
EUDRAGIT L100-55 | 25 |
磷酸二氢钾 | 5 |
微晶纤维素 | 26 |
乳糖 | 89 |
羧甲基淀粉钠 | 5 |
聚乙烯吡咯烷酮K-30 | 6 |
PEG4000 | 4 |
纯化水 | 80 |
主药及辅料名称 | 重量(克) |
盐酸尼卡地平 | 40 |
EUDRAGIT S100 | 22 |
氯化铵 | 8 |
微晶纤维素 | 25 |
乳糖 | 90 |
羧甲基淀粉钠 | 5 |
聚乙烯吡咯烷酮K-30 | 6 |
PEG4000 | 4 |
纯化水 | 80 |
主药及辅料名称 | 重量(克) |
盐酸尼卡地平 | 40 |
邻苯二甲酸羟丙基甲基纤维素(HPMCP) | 20 |
二乙胺盐酸盐 | 6 |
微晶纤维素 | 25 |
乳糖 | 60 |
甘露醇 | 34 |
交联聚乙烯吡咯烷酮 | 5 |
聚乙烯吡咯烷酮K-30 | 10 |
纯化水 | 80 |
物料名称 | 重量(克) | 每粒胶囊装量 |
盐酸尼卡地平胃溶微丸 | 110 | 255mg |
盐酸尼卡地平肠溶缓释微丸 | 150 | |
微粉硅胶 | 2 |
溶出时间 | 1小时 | 2小时 | 4小时 | 8小时 | 12小时 |
溶出介质 | 900ml盐酸溶液(取盐酸14ml,加氯化钠4g,加水使溶解,并稀释至2000ml) | 900ml磷酸盐缓冲液(含0.1%的聚山梨酯80,pH=6.5) | 溶出介质同2小时 | 溶出介质同2小时 | 溶出介质同2小时 |
盐酸尼卡地释放量 | 27% | 32% | 49% | 73% | 87% |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200710019925A CN100579525C (zh) | 2007-02-02 | 2007-02-02 | 盐酸尼卡地平缓释制剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200710019925A CN100579525C (zh) | 2007-02-02 | 2007-02-02 | 盐酸尼卡地平缓释制剂及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101011395A true CN101011395A (zh) | 2007-08-08 |
CN100579525C CN100579525C (zh) | 2010-01-13 |
Family
ID=38699230
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200710019925A Expired - Fee Related CN100579525C (zh) | 2007-02-02 | 2007-02-02 | 盐酸尼卡地平缓释制剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100579525C (zh) |
Cited By (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101229132B (zh) * | 2008-02-03 | 2010-11-24 | 济南宏瑞创博医药科技开发有限公司 | 尼莫地平脉冲缓释微丸制剂及其制备方法 |
CN102821757A (zh) * | 2010-02-03 | 2012-12-12 | 格吕伦塔尔有限公司 | 通过挤出机制备粉末状药物组合物 |
US8722086B2 (en) | 2007-03-07 | 2014-05-13 | Gruenenthal Gmbh | Dosage form with impeded abuse |
US9161917B2 (en) | 2008-05-09 | 2015-10-20 | Grünenthal GmbH | Process for the preparation of a solid dosage form, in particular a tablet, for pharmaceutical use and process for the preparation of a precursor for a solid dosage form, in particular a tablet |
CN105287435A (zh) * | 2015-12-07 | 2016-02-03 | 黑龙江省智诚医药科技有限公司 | 一种盐酸尼卡地平缓释微丸及其制备方法 |
US9629807B2 (en) | 2003-08-06 | 2017-04-25 | Grünenthal GmbH | Abuse-proofed dosage form |
US9636303B2 (en) | 2010-09-02 | 2017-05-02 | Gruenenthal Gmbh | Tamper resistant dosage form comprising an anionic polymer |
US9655853B2 (en) | 2012-02-28 | 2017-05-23 | Grünenthal GmbH | Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer |
US9675610B2 (en) | 2002-06-17 | 2017-06-13 | Grünenthal GmbH | Abuse-proofed dosage form |
CN106902097A (zh) * | 2015-12-21 | 2017-06-30 | 瑞普(天津)生物药业有限公司 | 一种可改善药物生物利用度的药物组合物 |
US9737490B2 (en) | 2013-05-29 | 2017-08-22 | Grünenthal GmbH | Tamper resistant dosage form with bimodal release profile |
US9750701B2 (en) | 2008-01-25 | 2017-09-05 | Grünenthal GmbH | Pharmaceutical dosage form |
US9855263B2 (en) | 2015-04-24 | 2018-01-02 | Grünenthal GmbH | Tamper-resistant dosage form with immediate release and resistance against solvent extraction |
US9872835B2 (en) | 2014-05-26 | 2018-01-23 | Grünenthal GmbH | Multiparticles safeguarded against ethanolic dose-dumping |
US9913814B2 (en) | 2014-05-12 | 2018-03-13 | Grünenthal GmbH | Tamper resistant immediate release capsule formulation comprising tapentadol |
US9925146B2 (en) | 2009-07-22 | 2018-03-27 | Grünenthal GmbH | Oxidation-stabilized tamper-resistant dosage form |
US10058548B2 (en) | 2003-08-06 | 2018-08-28 | Grünenthal GmbH | Abuse-proofed dosage form |
US10064945B2 (en) | 2012-05-11 | 2018-09-04 | Gruenenthal Gmbh | Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc |
US10080721B2 (en) | 2009-07-22 | 2018-09-25 | Gruenenthal Gmbh | Hot-melt extruded pharmaceutical dosage form |
US10130591B2 (en) | 2003-08-06 | 2018-11-20 | Grünenthal GmbH | Abuse-proofed dosage form |
US10154966B2 (en) | 2013-05-29 | 2018-12-18 | Grünenthal GmbH | Tamper-resistant dosage form containing one or more particles |
US10201502B2 (en) | 2011-07-29 | 2019-02-12 | Gruenenthal Gmbh | Tamper-resistant tablet providing immediate drug release |
US10300141B2 (en) | 2010-09-02 | 2019-05-28 | Grünenthal GmbH | Tamper resistant dosage form comprising inorganic salt |
US10335373B2 (en) | 2012-04-18 | 2019-07-02 | Grunenthal Gmbh | Tamper resistant and dose-dumping resistant pharmaceutical dosage form |
US10449547B2 (en) | 2013-11-26 | 2019-10-22 | Grünenthal GmbH | Preparation of a powdery pharmaceutical composition by means of cryo-milling |
US10624862B2 (en) | 2013-07-12 | 2020-04-21 | Grünenthal GmbH | Tamper-resistant dosage form containing ethylene-vinyl acetate polymer |
US10695297B2 (en) | 2011-07-29 | 2020-06-30 | Grünenthal GmbH | Tamper-resistant tablet providing immediate drug release |
US10729658B2 (en) | 2005-02-04 | 2020-08-04 | Grünenthal GmbH | Process for the production of an abuse-proofed dosage form |
US10842750B2 (en) | 2015-09-10 | 2020-11-24 | Grünenthal GmbH | Protecting oral overdose with abuse deterrent immediate release formulations |
US11224576B2 (en) | 2003-12-24 | 2022-01-18 | Grünenthal GmbH | Process for the production of an abuse-proofed dosage form |
WO2022141749A1 (zh) * | 2020-12-30 | 2022-07-07 | 江苏大学 | 一种pH智能响应的控释抗菌包装纤维膜的制备方法 |
US11844865B2 (en) | 2004-07-01 | 2023-12-19 | Grünenthal GmbH | Abuse-proofed oral dosage form |
-
2007
- 2007-02-02 CN CN200710019925A patent/CN100579525C/zh not_active Expired - Fee Related
Cited By (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9675610B2 (en) | 2002-06-17 | 2017-06-13 | Grünenthal GmbH | Abuse-proofed dosage form |
US10369109B2 (en) | 2002-06-17 | 2019-08-06 | Grünenthal GmbH | Abuse-proofed dosage form |
US9629807B2 (en) | 2003-08-06 | 2017-04-25 | Grünenthal GmbH | Abuse-proofed dosage form |
US10058548B2 (en) | 2003-08-06 | 2018-08-28 | Grünenthal GmbH | Abuse-proofed dosage form |
US10130591B2 (en) | 2003-08-06 | 2018-11-20 | Grünenthal GmbH | Abuse-proofed dosage form |
US11224576B2 (en) | 2003-12-24 | 2022-01-18 | Grünenthal GmbH | Process for the production of an abuse-proofed dosage form |
US11844865B2 (en) | 2004-07-01 | 2023-12-19 | Grünenthal GmbH | Abuse-proofed oral dosage form |
US10729658B2 (en) | 2005-02-04 | 2020-08-04 | Grünenthal GmbH | Process for the production of an abuse-proofed dosage form |
US10675278B2 (en) | 2005-02-04 | 2020-06-09 | Grünenthal GmbH | Crush resistant delayed-release dosage forms |
US8722086B2 (en) | 2007-03-07 | 2014-05-13 | Gruenenthal Gmbh | Dosage form with impeded abuse |
US9750701B2 (en) | 2008-01-25 | 2017-09-05 | Grünenthal GmbH | Pharmaceutical dosage form |
CN101229132B (zh) * | 2008-02-03 | 2010-11-24 | 济南宏瑞创博医药科技开发有限公司 | 尼莫地平脉冲缓释微丸制剂及其制备方法 |
US9161917B2 (en) | 2008-05-09 | 2015-10-20 | Grünenthal GmbH | Process for the preparation of a solid dosage form, in particular a tablet, for pharmaceutical use and process for the preparation of a precursor for a solid dosage form, in particular a tablet |
US10493033B2 (en) | 2009-07-22 | 2019-12-03 | Grünenthal GmbH | Oxidation-stabilized tamper-resistant dosage form |
US10080721B2 (en) | 2009-07-22 | 2018-09-25 | Gruenenthal Gmbh | Hot-melt extruded pharmaceutical dosage form |
US9925146B2 (en) | 2009-07-22 | 2018-03-27 | Grünenthal GmbH | Oxidation-stabilized tamper-resistant dosage form |
CN102821757A (zh) * | 2010-02-03 | 2012-12-12 | 格吕伦塔尔有限公司 | 通过挤出机制备粉末状药物组合物 |
CN102821757B (zh) * | 2010-02-03 | 2016-01-20 | 格吕伦塔尔有限公司 | 通过挤出机制备粉末状药物组合物 |
US10300141B2 (en) | 2010-09-02 | 2019-05-28 | Grünenthal GmbH | Tamper resistant dosage form comprising inorganic salt |
US9636303B2 (en) | 2010-09-02 | 2017-05-02 | Gruenenthal Gmbh | Tamper resistant dosage form comprising an anionic polymer |
US10201502B2 (en) | 2011-07-29 | 2019-02-12 | Gruenenthal Gmbh | Tamper-resistant tablet providing immediate drug release |
US10864164B2 (en) | 2011-07-29 | 2020-12-15 | Grünenthal GmbH | Tamper-resistant tablet providing immediate drug release |
US10695297B2 (en) | 2011-07-29 | 2020-06-30 | Grünenthal GmbH | Tamper-resistant tablet providing immediate drug release |
US9655853B2 (en) | 2012-02-28 | 2017-05-23 | Grünenthal GmbH | Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer |
US10335373B2 (en) | 2012-04-18 | 2019-07-02 | Grunenthal Gmbh | Tamper resistant and dose-dumping resistant pharmaceutical dosage form |
US10064945B2 (en) | 2012-05-11 | 2018-09-04 | Gruenenthal Gmbh | Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc |
US9737490B2 (en) | 2013-05-29 | 2017-08-22 | Grünenthal GmbH | Tamper resistant dosage form with bimodal release profile |
US10154966B2 (en) | 2013-05-29 | 2018-12-18 | Grünenthal GmbH | Tamper-resistant dosage form containing one or more particles |
US10624862B2 (en) | 2013-07-12 | 2020-04-21 | Grünenthal GmbH | Tamper-resistant dosage form containing ethylene-vinyl acetate polymer |
US10449547B2 (en) | 2013-11-26 | 2019-10-22 | Grünenthal GmbH | Preparation of a powdery pharmaceutical composition by means of cryo-milling |
US9913814B2 (en) | 2014-05-12 | 2018-03-13 | Grünenthal GmbH | Tamper resistant immediate release capsule formulation comprising tapentadol |
US9872835B2 (en) | 2014-05-26 | 2018-01-23 | Grünenthal GmbH | Multiparticles safeguarded against ethanolic dose-dumping |
US9855263B2 (en) | 2015-04-24 | 2018-01-02 | Grünenthal GmbH | Tamper-resistant dosage form with immediate release and resistance against solvent extraction |
US10842750B2 (en) | 2015-09-10 | 2020-11-24 | Grünenthal GmbH | Protecting oral overdose with abuse deterrent immediate release formulations |
CN105287435A (zh) * | 2015-12-07 | 2016-02-03 | 黑龙江省智诚医药科技有限公司 | 一种盐酸尼卡地平缓释微丸及其制备方法 |
CN106902097B (zh) * | 2015-12-21 | 2020-01-07 | 瑞普(天津)生物药业有限公司 | 一种可改善药物生物利用度的药物组合物 |
CN106902097A (zh) * | 2015-12-21 | 2017-06-30 | 瑞普(天津)生物药业有限公司 | 一种可改善药物生物利用度的药物组合物 |
WO2022141749A1 (zh) * | 2020-12-30 | 2022-07-07 | 江苏大学 | 一种pH智能响应的控释抗菌包装纤维膜的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN100579525C (zh) | 2010-01-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100579525C (zh) | 盐酸尼卡地平缓释制剂及其制备方法 | |
TWI778268B (zh) | 含有葡萄糖激酶啟動劑和sglt-2抑制劑的藥物組合及其製備方法和用途 | |
JP5285913B2 (ja) | 経口投与できる固体の放出改変型医薬投与形 | |
US11331274B2 (en) | Milrinone controlled-release formulation | |
AU2007307482A1 (en) | Combined preparation for the treatment of cardiovascular diseases based on chronotherapy theory | |
JPH06239738A (ja) | S(+)イブプロフェンを含有する薬剤 | |
CN108289848A (zh) | 包含urat1的有效抑制剂的药物组合物 | |
US20100247645A1 (en) | Pharmaceutical combination of aliskiren and valsartan | |
CN103417505A (zh) | 具有双相释药行为的石杉碱甲控释制剂及其制备方法 | |
KR20170098897A (ko) | 치료 방법 | |
CN112451531B (zh) | 一种阿司匹林和利伐沙班复方制剂及其制备方法 | |
CN106420738B (zh) | 一种左旋氨氯地平或其盐的缓释制剂及其制备方法 | |
CN102600451B (zh) | 一种非洛地平雷米普利复方缓释制剂及其制备方法 | |
CN102247326B (zh) | 一种普萘洛尔及其盐类口服择时控释微丸制剂 | |
WO2013189305A1 (zh) | 缬沙坦氨氯地平复方固体制剂及其制备方法 | |
CN101269056B (zh) | 一种美托洛尔盐类口服脉冲微丸制剂 | |
CN101773482B (zh) | 一种三段式脉冲释药控释片及其制备方法 | |
WO2015196956A1 (zh) | 美托洛尔缓释组合物及其制备方法 | |
CN102949406B (zh) | 一种复方艾夫他滨药物组合物及其制备方法和用途 | |
CN103315973A (zh) | 喹硫平的渗透泵型控释制剂 | |
JP2012515765A (ja) | 時間治療用医薬組成物 | |
CN101664377A (zh) | 尼卡地平缓释制剂及其制备方法 | |
WO2015170195A1 (en) | Hydrazaline hydrochloride pellets and its preparation method | |
WO2005030201A1 (fr) | Preparation a liberation prolongee contenant de l'hydrochlorothiazide et du carvedilol/atenolol | |
CN102342917A (zh) | 一种以尼伐地平为活性成分的缓释口服固体制剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Nanjing Tefeng Pharmaceutical Co., Ltd. Assignor: Southeast University Contract record no.: 2011320000974 Denomination of invention: Sustained release preparation of licardipine hydrochloride and its preparing process Granted publication date: 20100113 License type: Exclusive License Open date: 20070808 Record date: 20110713 |
|
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100113 Termination date: 20140202 |